| ￥3800 | |
| Z05082-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | |
| Protein Construction |
|
|
| Purity | > 95% as determined by BisTris PAGE | |
| Endotoxin Level | Less than 1EU per μg by the LAL method. | |
| Expression System | E.coli | |
| Theoretical Molecular Weight | 11.35 kDa | |
| Apparent Molecular Weight | The protein has a predicted MW of 11.35 kDa same as Bis-Tris PAGE result. | |
| Formulation | Lyophilized from 0.22μm filtered solution in PBS, 150mM NaCl (pH 7.4). | |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | |
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
The purity of BLOC1S2, Human is greater than 90% as determined by SEC-HPLC. »
BLOC1S2, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | BLOC1S2 (Biogenesis of lysosome-related organelles complex-1 subunit 2) protein is widely expressed in normal tissue as well as in malignant tumors with a tendency towards lower expression levels in certain subtypes of tumors. On the subcellular level, BLOC1S2 is expressed in an organellar-like pattern and co-localizes with mitochondria. |
| Synonyms | BLOC-1 subunit 2; BLOS2; CEAP; CEAP11 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
